Wordt geladen...
Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
The translation of cardioprotection from robust experimental evidence to beneficial clinical outcome for patients suffering acute myocardial infarction or undergoing cardiovascular surgery has been largely disappointing. The present review attempts to critically analyse the evidence for confounders...
Bewaard in:
| Gepubliceerd in: | Br J Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7680006/ https://ncbi.nlm.nih.gov/pubmed/31430831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14839 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|